EMA Authorised: Hepcludex (bulevirtide acetate) — Gilead Sciences Ireland UC

View source ↗

Summary

EMA authorised Hepcludex (bulevirtide) by Gilead Sciences Ireland UC for chronic hepatitis D.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Hepcludex (bulevirtide)

Snippet

Status: Authorised. Therapeutic area: Hepatitis D, Chronic. MAH: Gilead Sciences Ireland UC. Decision date: 12/03/2026. Orphan medicine